Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Rangit Reddy Vallapureddy
Observed names:
R Vallapureddy,
Rangit R. Vallapureddy,
Rangit Vallapureddy
Observed institution:
Mayo Clinic
OpenAlex ID:
A5080232575
3023 Mayo Clinic Patients With Myeloproliferative Neoplasms: Risk-Stratified Comparison of Survival and Outcomes Data Among Disease Subgroups
2019
·
Natasha Szuber
, Mythri Mudireddy
, et al.
·
Mayo Clinic Proceedings
·
168
Myeloproliferative neoplasms in the young: Mayo Clinic experience with 361 patients age 40 years or younger
2018
·
Natasha Szuber
, Rangit R. Vallapureddy
, et al.
·
American Journal of Hematology
·
98
PDF
Flow cytometry based monocyte subset analysis accurately distinguishes chronic myelomonocytic leukemia from myeloproliferative neoplasms with associated monocytosis
2017
·
M M Patnaik
, M M Timm
, et al.
·
Blood Cancer Journal
·
80
PDF
Aurora Kinase A Inhibition Provides Clinical Benefit, Normalizes Megakaryocytes, and Reduces Bone Marrow Fibrosis in Patients with Myelofibrosis: A Phase I Trial
2019
·
Naseema Gangat
, Christian Marinaccio
, et al.
·
Clinical Cancer Research
·
77
Urinary Extracellular Vesicles of Podocyte Origin and Renal Injury in Preeclampsia
2017
·
Sarwat I. Gilani
, Ulrik Dolberg Anderson
, et al.
·
Journal of the American Society of Nephrology
·
76
Leukemic transformation among 1306 patients with primary myelofibrosis: risk factors and development of a predictive model
2019
·
Rangit R. Vallapureddy
, Mythri Mudireddy
, et al.
·
Blood Cancer Journal
·
75
PDF
Suboptimal response rates to hypomethylating agent therapy in chronic myelomonocytic leukemia; a single institutional study of 121 patients
2019
·
Tucker Coston
, Prateek Pophali
, et al.
·
American Journal of Hematology
·
72
PDF
Therapy related‐chronic myelomonocytic leukemia (CMML): Molecular, cytogenetic, and clinical distinctions from de novo CMML
2017
·
Mrinal M. Patnaik
, Rangit Vallapureddy
, et al.
·
American Journal of Hematology
·
60
PDF
EZH2 mutations in chronic myelomonocytic leukemia cluster with ASXL1 mutations and their co-occurrence is prognostically detrimental
2018
·
Mrinal M. Patnaik
, Rangit Vallapureddy
, et al.
·
Blood Cancer Journal
·
53
PDF
Nucleophosmin 1 (NPM1) mutations in chronic myelomonocytic leukemia and their prognostic relevance
2017
·
Rangit Vallapureddy
, Terra L. Lasho
, et al.
·
American Journal of Hematology
·
44
Blast phase chronic myelomonocytic leukemia: Mayo-MDACC collaborative study of 171 cases
2018
·
Mrinal M. Patnaik
, Ana A. Pierola
, et al.
·
Leukemia
·
36
3,023 Mayo Clinic Patients with Myeloproliferative Neoplasms: Risk-Stratified Comparison of Survival and Outcomes Data Among Disease Subgroups
2018
·
Natasha Szuber
, Mythri Mudireddy
, et al.
·
Blood
·
35
A comparison of clinical and molecular characteristics of patients with systemic mastocytosis with chronic myelomonocytic leukemia to CMML alone
2018
·
Mrinal M. Patnaik
, Rangit Vallapureddy
, et al.
·
Leukemia
·
30
Nonhepatosplenic extramedullary manifestations of chronic myelomonocytic leukemia: clinical, molecular and prognostic correlates
2018
·
Katherine Hoversten
, Rangit Vallapureddy
, et al.
·
Leukemia & lymphoma/Leukemia and lymphoma
·
22
Decreased survival and increased rate of fibrotic progression in essential thrombocythemia chronicled after the FDA approval date of anagrelide
2018
·
Ayalew Tefferi
, Natasha Szuber
, et al.
·
American Journal of Hematology
·
20
PDF
Lenalidomide therapy in patients with myelodysplastic syndrome/myeloproliferative neoplasm with ring sideroblasts and thrombocytosis (MDS/MPN‐RS‐T)
2017
·
Maura Nicolosi
, Mythri Mudireddy
, et al.
·
American Journal of Hematology
·
20
PDF
Infrequent occurrence of TET1, TET3, and ASXL2 mutations in myelodysplastic/myeloproliferative neoplasms
2018
·
Terra L. Lasho
, Rangit Vallapureddy
, et al.
·
Blood Cancer Journal
·
15
PDF
20+ Years and alive with primary myelofibrosis: Phenotypic signature of very long‐lived patients
2018
·
Domenico Penna
, Terra L. Lasho
, et al.
·
American Journal of Hematology
·
14
PDF
Serum erythropoietin levels in essential thrombocythemia: phenotypic and prognostic correlates
2018
·
Natasha Szuber
, Sravanthi Lavu
, et al.
·
Blood Cancer Journal
·
12
PDF
A prospective evaluation of vitamin B1 (thiamine) level in myeloproliferative neoplasms: clinical correlations and impact of JAK2 inhibitor therapy
2019
·
Naseema Gangat
, Amy Phelps
, et al.
·
Blood Cancer Journal
·
11
PDF
Mutation-Enhanced International Prognostic Systems for Essential Thrombocythemia (MIPSS-ET) and Polycythemia Vera (MIPSS-PV)
2018
·
Ayalew Tefferi
, Paola Guglielmelli
, et al.
·
Blood
·
7
Cytogenetic clonal evolution in myeloproliferative neoplasms: contexts and prognostic impact among 648 patients with serial bone marrow biopsies
2019
·
Ayalew Tefferi
, Maura Nicolosi
, et al.
·
Leukemia
·
4
Mutations and Thrombosis in Essential Thrombocythemia and Polycythemia Vera: Mayo-Careggi Alliance Study
2018
·
Paola Guglielmelli
, Naseema Gangat
, et al.
·
Blood
·
2
The impact of sex on disease phenotype and prognostic thresholds of anemia in myelodysplastic syndromes
2018
·
Domenico Penna
, Maura Nicolosi
, et al.
·
American Journal of Hematology
·
2
20+ Years and Alive with Primary Myelofibrosis: Phenotypic Signature of Very Long-Lived Patients
2018
·
Domenico Penna
, Maura Nicolosi
, et al.
·
Blood
·
1
Show more works
View as search
Works count:
38
Citation count:
1,037
H-index:
16
I10-index:
20
Year
Topic
Type
